Hi Franc,
mid you look at my recent thread called “Triton or Re-AKT” you will see that the Triton study is about trialling a PARP inhibitor.
i don’t know if it is the same drug because I am having problems following the link, but to go on the trial for Rucaparib, it is necessary to have one of a number of gene mutations. Apparently, only one in ten men are likely to have the mutation.
I am currently awaiting the results of tests to see if I am eligible.
Unfortunately, I have been overtaken by events, since I have developed crippling backache, and resolving that has become the priority, but hopefully if that resolves and I am eligible for the trial, I may well be part of the study.
best wishes
peter